Combining bioprinting with imaging for glioblastomas

Researchers have reported success in the development of a novel methodology, combining 3D bioprinting and the imaging of glioblastoma cells. A multidisciplinary team of researchers from Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai (both NY, USA) has reported success in the development of a novel methodology, combining 3D bioprinting and the imaging of glioblastoma cells. Described in Science Advances, the team hopes that by combining these technologies, there is potential for a cost-effective methodology for modeling what happens with glioblastoma cells within the body. "There is a need to understand the biology and the complexity...